View Older Stories View More Recent Stories
-
Lazard Capital Upgrades SunPower (SPWR) to Buy
-
CVC Capital to Acquire Italian Credit Info Provider Cerved in $1.49B Deal
-
Notable Mergers and Acquisitions of the Day 12/24: (EOG)/(CVX) (VTR)
-
Ventas (VTR), Management Acquire All of Atria Senior Living
-
Värde Partners to Acquire FirstCity (FCFC) for $10/Share
-
Enzon Pharma (ENZN) to Trim Workforce by About Half
-
Intuitive Surgical (ISRG) Still Mum on Citron Report, But Analysts Weigh-In
-
Cerberus may tap Lazard for Freedom Group sale - WSJ
-
Pacific Ethanol (PEIX) to Increase Plant Debt Ownership, Extend Certain Maturities
-
Orexigen (OREX) Slumps as Many Expected 'Better News' for Contrave
-
Lazard Capital Downgrades Trimble Navigation (TRMB) to Neutral
-
Lazard Capital Starts Tim Hortons (THI) at Neutral
-
Notable Mergers and Acquisitions of the Day 12/17: (AIG) (S)/(CLWR) (CPWR) (ENZN) (CBOU)
-
StreetInsider.com Pre-Open Movers 12/17: (CBOU) (ENZN) (LXRX) Higher; (CLWR) (SQNM) (AG) Lower (more...)
-
Enzon Pharmaceuticals (ENZN) Suspends Clinical Development, To Explore a Sale
-
Cytori (CYTX) Prices 7.02M Offering at $2.85/Share
-
Sarepta Therapeutics (SRPT) 4.95M Share Offering Priced at $25.25
-
Sarepta Therapeutics (SRPT) Announces Common Stock Offering
-
Lazard (LAZ) Declares $0.20 Special Dividend; 0.6% Yield
-
Lazard (LAZ) Declares $0.20 Quarterly Dividend; 2.6% Yield
-
Notable Analyst Rating Changes 12/11: (CNX) (CBI) (MNST) Upgraded; (CBL) (ARW) (LPL) Downgraded
-
Lazard Capital Downgrades Foster Wheeler (FWLT) to Neutral
-
Lazard Capital Upgrades Chicago Bridge & Iron (CBI) to Buy
-
Notable Analyst Rating Changes 12/10: (TRIP) (ANF) (SWFT) Upgraded; (GTI) (CME) (X) Downgraded
-
Lazard Capital Starts Ruckus Wireless (RKUS) at Buy
-
Lazard Capital Downgrades McGraw-Hill (MHP) to Hold
-
Lazard Capital Cuts PT on Amarin (AMRN) to $16
-
Lazard Capital Starts ON Semi (ONNN) at Neutral
-
Lazard Capital Starts Atmel (ATML) at Neutral
-
NovaBay Pharma (NBY) Prices 5.9M Common Offering at $1.25/Share
-
NovaBay Pharma (NBY) Announces Common Offering
-
Lazard Capital Starts Supernus Pharmaceuticals (SUPN) at Buy
-
Lazard Capital Starts Covanta (CVA) at Buy
-
CreXus Investment (CXS) Taps Lazard to Advise on Annaly (NLY) Bid
-
Raymond James Starts Lazard (LAZ) at Outperform
-
Analysts, Physicians Positive on FDA Approval of Exelixis' (EXEL) Cabozantinib into Meeting
-
Notable Analyst Rating Changes 11/26: (RIMM) (YHOO) (FB) Upgraded; (MCD) (ARO) (ILMN) Downgraded
-
Lazard Capital Downgrades McDonald's (MCD) to Neutral
-
Notable Analyst Rating Changes 11/21: (PENN) (THOR) (SKX) Upgraded; (HTWR) (EV) (ICA) Downgraded
-
Lazard Capital Upgrades Penn National Gaming (PENN) to Buy
-
Lazard Capital Starts WellPoint (WLP) at Neutral
-
Lazard Capital Starts UnitedHealth Group (UNH) at Buy
-
Lazard Capital Starts Aetna (AET) at Buy
-
CNH Global (CNH) Affirms Fiat Industrial Bid; Will Review Proposal
-
Notable Mergers and Acquisitions of the Day 11/16: (PENN) (SHF) (OUTD) (HTZ)/(DTG) More...
-
Outdoor Channel (OUTD) Enters Merger with InterMedia Outdoors
-
Stocks Crossing 50-Day SMA 11/13: (DVAX) (ARNA) (DKS) Above; (CELG) (ALU) (PMT) Below
-
Notable Analyst Rating Changes 11/13: (ALB) (EV) (DDD) Upgraded; (MCP) (LYB) (JNS) Downgraded
-
Lazard Capital Starts Berry Plastics Group (BERY) at Buy
-
Unusual 11 Mid-Day Movers 11/12: (TIE) (STV) (LDK) Higher; (GALE) (CLVS) (STSI) Lower

